Use of mutant 125I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells

Animal cells strictly control the distribution of cholesterol in their organelle membranes. This regulation requires an efficient machinery to transport insoluble cholesterol between organelles. In the present study, we generate an 125I-labeled mutant version of Perfringolysin O (PFO), a cholesterol-binding protein, and use it to measure cholesterol in the plasma membrane of intact cells. We also purify plasma membranes from the same cells, which allows us to directly relate cholesterol concentration to 125I-PFO binding. We show that cholesterol is organized in the plasma membrane in a manner that makes it inaccessible to PFO until its concentration exceeds a threshold of 35 mol% of total lipids. This 35% threshold is in striking contrast to the 5% threshold previously found for PFO binding to endoplasmic reticulum membranes. The 125I-PFO probe also proved useful in monitoring the movement of LDL-derived cholesterol from lysosomes to plasma membranes. Using three different mutant cell lines, we show that this transport requires receptor-mediated uptake of LDL, hydrolysis of LDL-cholesteryl esters in lysosomes, and transfer of the liberated cholesterol to the plasma membrane.

[1]  T. Steck,et al.  Circulation of Cholesterol between Lysosomes and the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[2]  J. Flanagan,et al.  Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. , 2009, Biochemistry.

[3]  Y. Lange Tracking cell cholesterol with cholesterol oxidase. , 1992, Journal of lipid research.

[4]  M. Brown,et al.  The LDL receptor locus and the genetics of familial hypercholesterolemia. , 1979, Annual review of genetics.

[5]  L. Liscum,et al.  Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. , 1996, Journal of lipid research.

[6]  J. McDonald,et al.  Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. , 2008, Cell metabolism.

[7]  L. Liscum,et al.  Evidence for a Cholesterol Transport Pathway from Lysosomes to Endoplasmic Reticulum That Is Independent of the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[8]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[9]  Y. Shimada,et al.  Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization. , 2010, Sub-cellular biochemistry.

[10]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts , 1989, The Journal of cell biology.

[11]  G. Gimpl,et al.  Probes for studying cholesterol binding and cell biology , 2011, Steroids.

[12]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[13]  C deDuve,et al.  Tissue fractionation. Past and present. , 1971 .

[14]  D. Russell,et al.  The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.

[15]  Y. Shimada,et al.  The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. , 2002, European journal of biochemistry.

[16]  L. Liscum,et al.  Intracellular cholesterol transport. , 1999, Biochimica et biophysica acta.

[17]  A. Radhakrishnan,et al.  Accessibility of Cholesterol in Endoplasmic Reticulum Membranes and Activation of SREBP-2 Switch Abruptly at a Common Cholesterol Threshold , 2010, The Journal of Biological Chemistry.

[18]  J. Goldstein,et al.  Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. , 2002, Molecular cell.

[19]  D. Czajkowsky,et al.  Monomer-Monomer Interactions Drive the Prepore to Pore Conversion of a β-Barrel-forming Cholesterol-dependent Cytolysin* , 2002, The Journal of Biological Chemistry.

[20]  R. Aebersold,et al.  Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.

[21]  R. Brady,et al.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[23]  Christian de Duve,et al.  Tissue fraction-past and present. , 1971 .

[24]  E. Goldberg,et al.  Lactate dehydrogenase isozymes from mouse. , 1982, Methods in enzymology.

[25]  Toshihide Kobayashi,et al.  Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution[S] , 2011, Journal of Lipid Research.

[26]  M. Brown,et al.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. , 1978, The Journal of biological chemistry.

[27]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[28]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  M. Brown,et al.  Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. , 1976, The Journal of biological chemistry.

[30]  M. Swaisgood,et al.  Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. , 1989, The Journal of biological chemistry.

[31]  M. Brown,et al.  Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. , 1975, The Journal of biological chemistry.

[32]  C. Korzeniewski,et al.  An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.

[33]  E. London,et al.  How Interaction of Perfringolysin O with Membranes Is Controlled by Sterol Structure, Lipid Structure, and Physiological Low pH , 2008, Journal of Biological Chemistry.

[34]  W. J. Johnson,et al.  Cellular Cholesterol Efflux Mediated by Cyclodextrins (*) , 1995, The Journal of Biological Chemistry.

[35]  B. Wattenberg,et al.  Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution. , 1983, The Journal of biological chemistry.